A detailed history of Sandy Spring Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sandy Spring Bank holds 93,151 shares of BMY stock, worth $5.37 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
93,151
Previous 102,753 9.34%
Holding current value
$5.37 Million
Previous $4.27 Million 12.96%
% of portfolio
0.2%
Previous 0.19%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$39.66 - $51.75 $380,815 - $496,903
-9,602 Reduced 9.34%
93,151 $4.82 Million
Q2 2024

Aug 06, 2024

SELL
$40.25 - $52.99 $140,714 - $185,253
-3,496 Reduced 3.29%
102,753 $4.27 Million
Q1 2024

May 08, 2024

SELL
$47.98 - $54.4 $142,164 - $161,187
-2,963 Reduced 2.71%
106,249 $5.76 Million
Q4 2023

Jan 26, 2024

SELL
$48.48 - $57.85 $471,516 - $562,649
-9,726 Reduced 8.18%
109,212 $5.6 Million
Q3 2023

Oct 30, 2023

SELL
$57.89 - $64.73 $30,913 - $34,565
-534 Reduced 0.45%
118,938 $6.9 Million
Q2 2023

Aug 04, 2023

SELL
$63.71 - $70.74 $149,718 - $166,239
-2,350 Reduced 1.93%
119,472 $7.64 Million
Q1 2023

May 05, 2023

SELL
$65.71 - $74.53 $110,984 - $125,881
-1,689 Reduced 1.37%
121,822 $8.44 Million
Q4 2022

Feb 10, 2023

SELL
$68.48 - $81.09 $306,584 - $363,039
-4,477 Reduced 3.5%
123,511 $8.89 Million
Q3 2022

Nov 02, 2022

SELL
$0.13 - $76.84 $1,206 - $712,844
-9,277 Reduced 6.76%
127,988 $9.1 Million
Q2 2022

Jul 21, 2022

SELL
$72.62 - $79.98 $212,558 - $234,101
-2,927 Reduced 2.09%
137,265 $10.6 Million
Q1 2022

May 03, 2022

SELL
$61.48 - $73.72 $8.38 Million - $10 Million
-136,227 Reduced 49.28%
140,192 $10.2 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $7.19 Million - $8.38 Million
134,052 Added 94.16%
276,419 $17.3 Million
Q3 2021

Nov 05, 2021

SELL
$59.17 - $69.31 $102,127 - $119,629
-1,726 Reduced 1.2%
142,367 $8.42 Million
Q2 2021

Aug 09, 2021

BUY
$61.91 - $67.42 $97,755 - $106,456
1,579 Added 1.11%
144,093 $9.63 Million
Q1 2021

May 03, 2021

BUY
$59.34 - $66.74 $318,418 - $358,126
5,366 Added 3.91%
142,514 $9 Million
Q4 2020

Feb 03, 2021

SELL
$57.74 - $65.43 $202,263 - $229,201
-3,503 Reduced 2.49%
137,148 $8.51 Million
Q3 2020

Nov 09, 2020

BUY
$57.43 - $63.64 $133,582 - $148,026
2,326 Added 1.68%
140,651 $8.48 Million
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $117,314 - $137,152
2,140 Added 1.57%
138,325 $8.13 Million
Q1 2020

May 01, 2020

SELL
$46.4 - $67.43 $257,241 - $373,831
-5,544 Reduced 3.91%
136,185 $7.59 Million
Q4 2019

Feb 06, 2020

BUY
$49.21 - $64.19 $95,811 - $124,977
1,947 Added 1.39%
141,729 $9.1 Million
Q3 2019

Nov 01, 2019

BUY
$42.77 - $50.71 $45,721 - $54,208
1,069 Added 0.77%
139,782 $7.09 Million
Q2 2019

Aug 01, 2019

SELL
$44.62 - $49.34 $197,978 - $218,921
-4,437 Reduced 3.1%
138,713 $6.29 Million
Q1 2019

May 06, 2019

BUY
$45.12 - $53.8 $170,237 - $202,987
3,773 Added 2.71%
143,150 $6.83 Million
Q4 2018

Feb 08, 2019

SELL
$48.76 - $63.23 $203,377 - $263,732
-4,171 Reduced 2.91%
139,377 $7.25 Million
Q3 2018

Nov 07, 2018

BUY
$55.19 - $62.25 $993 - $1,120
18 Added 0.01%
143,548 $8.91 Million
Q2 2018

Aug 03, 2018

BUY
$50.53 - $62.98 $155,430 - $193,726
3,076 Added 2.19%
143,530 $7.94 Million
Q1 2018

May 04, 2018

BUY
$59.92 - $68.98 $657,622 - $757,055
10,975 Added 8.48%
140,454 $8.88 Million
Q4 2017

Feb 02, 2018

BUY
$59.94 - $65.35 $413,586 - $450,914
6,900 Added 5.63%
129,479 $7.93 Million
Q3 2017

Nov 03, 2017

BUY
$55.23 - $63.74 $163,259 - $188,415
2,956 Added 2.47%
122,579 $7.81 Million
Q2 2017

Aug 11, 2017

BUY
N/A
119,623
119,623 $6.71 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.